Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.74 USD | +5.64% | -0.87% | +77.18% |
Financials (USD)
Sales 2024 * | 197M | Sales 2025 * | 218M | Capitalization | 858M |
---|---|---|---|---|---|
Net income 2024 * | -54M | Net income 2025 * | -52M | EV / Sales 2024 * | 4.29 x |
Net cash position 2024 * | 11.13M | Net cash position 2025 * | 41.33M | EV / Sales 2025 * | 3.74 x |
P/E ratio 2024 * |
-15.9
x | P/E ratio 2025 * |
-16.6
x | Employees | 474 |
Yield 2024 * |
0.58% | Yield 2025 * |
-
| Free-Float | 95.74% |
Latest transcript on Silk Road Medical, Inc
1 day | +5.64% | ||
1 week | -0.87% | ||
1 month | +11.83% | ||
3 months | +20.84% | ||
6 months | +133.01% | ||
Current year | +77.18% |
Managers | Title | Age | Since |
---|---|---|---|
Charles McKhann
CEO | Chief Executive Officer | 55 | Nov. 01 |
Lucas Buchanan
DFI | Director of Finance/CFO | 46 | 09-07-31 |
William Whealon
CTO | Chief Tech/Sci/R&D Officer | - | 20-09-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Don Zurbay
BRD | Director/Board Member | 56 | 18-03-25 |
Kevin Ballinger
BRD | Director/Board Member | 51 | 20-12-02 |
Jack Lasersohn
CHM | Chairman | 71 | 07-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 21.74 | +5.64% | 1,959,115 |
24-05-30 | 20.58 | -3.24% | 633,633 |
24-05-29 | 21.27 | -0.37% | 504,439 |
24-05-28 | 21.35 | -2.64% | 683,269 |
24-05-24 | 21.93 | +1.86% | 385,326 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.18% | 858M | |
-7.16% | 178B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- SILK Stock